Dipa Kumar, MS, PMP, currently serves as the Director and Platform Lead for Clinical Operations at BioNTech SE since September 2021. Prior roles include Clinical Study Lead in Oncology at Regeneron Pharmaceuticals from June 2020 to September 2021 and Senior Manager of Clinical Trial Management at Celgene, where responsibilities involved leading Global Lymphoma studies and providing program-level feasibility. Dipa Kumar has extensive experience at Merck, holding various positions from February 1998 to November 2013, including Global Meeting Manager, Senior Clinical Trial Manager, Clinical Research Scientist, Data Management Specialist, Information Management Specialist, and Scientist. Academic credentials include a Master’s Degree in Biomedical Informatics in Clinical Research from Rutgers School of Health Professions and a Bachelor of Science in Biotechnology from Rutgers University.
This person is not in any teams
This person is not in any offices